PharmiWeb.com - Global Pharma News & Resources
14-Jun-2019

Vaccine Technologies Market Global Size, Growth, Regions, Type and Application, Status Forecast by 2019-2024

Market Research Engine has published a new report titled asVaccine Technologies Market Size, By Human Vaccine (Attenuated (Live) Vaccines, Inactivated Vaccines, Conjugate Vaccines, rDNA/DNA Vaccines, Subunit Vaccines, Toxoid Vaccines, Combination Vaccines, Vaccine by Age Group, Vaccine by Disease Type), By Animal Vaccines (Attenuated Vaccines, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, Conjugate Vaccines, Recombinant Vaccine, DNA Vaccine, Vaccine by Animal Type), By Region, Market Analysis Report, Forecast 2018-2024.”

Report scope:

The global vaccine technologies market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.

The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies. 

The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Astrazeneca, Boehringer Ingelheim, GE Healthcare, Glaxosmithkline, Johnson & Johnson, LG Life Sciences, Novartis, Merck, Serum Institute Of India, and Thermo Fisher Scientific.

Browse Full Report: https://www.marketresearchengine.com/vaccine-technologies-market

Global vaccine technologies market research report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional vaccine technologies market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Rising number of diseases and increasing population across the globe is positively affecting the vaccine technologies market size during the study period. Development of immunization programs across the emerging countries will support in increasing industry volume. Emergence of new pandemics will enhance the business growth.

Increasing expenditure in research activities together with rising competition is primarily driving the vaccine technologies market size over the forecast time span. Moreover, rising competition is promoting the industry players to introduce innovate products in the marketplace, thereby enhancing the industry revenue generation. Other factors such as changing lifestyles will further improve the industry size.

Global vaccine technologies market is segmented based on the human vaccine as, Attenuated (Live) Vaccines, Inactivated Vaccines, Conjugate Vaccines, rDNA/DNA Vaccines, Subunit Vaccines, Toxoid Vaccines, Combination Vaccines, Vaccine by Age Group, Vaccine by Disease Type. On the basis of animal vaccine, the global vaccine technologies market is segregated as Attenuated Vaccines, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, Conjugate Vaccines, Recombinant Vaccine, DNA Vaccine, Vaccine by Animal Type. Combination vaccines is expected to witness notable gains in the forecast years.

Competitive Rivalry

Global vaccine technologies market share consists of several players including Astrazeneca, Boehringer Ingelheim, GE Healthcare, Glaxosmithkline, Johnson & Johnson, LG Life Sciences, Novartis, Merck, Serum Institute of India, and Thermo Fisher Scientific.

The Vaccine Technologies Market has been segmented as below:

Vaccine Technologies Market, By Human Vaccine

  • Attenuated (Live) Vaccines
  • Inactivated Vaccines
  • Conjugate Vaccines
  • rDNA/DNA Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Combination Vaccines
  • Vaccine by Age Group
  • Vaccine by Disease Type

Vaccine Technologies Market, By Animal Vaccine

  • Attenuated Vaccines
  • Inactivated Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • Conjugate Vaccines
  • Recombinant Vaccine, DNA Vaccine
  • Vaccine by Animal Type

Vaccine Technologies Market, By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

The report covers:

  • Global vaccine technologies market estimates & forecast from 2015 to 2024, with CAGR for 2018-2024.
  • Comparative market size analysis for 2017 & 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
  • Global vaccine technologies market trends, with detailed analysis on consumer trends & manufacturer trends
  • Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
  • Key areas of investments identifying market opportunities and challenges in forecast timeframe
  • Competitive analysis of the industry players along with the overview on strategic management
  • Comprehensive company profiles of the major industry players

Reasons to Buy this Report:

  • Gain comprehensive insights on the industry trends
  • Identify industry opportunities and key growth segments
  • Obtain complete market study on the vaccine technologies market
  • Facilitate strategy planning for your company based on the industry dynamics
  • Evaluate your competitor’s business segments and portfolios

Request Sample Report from here: https://www.marketresearchengine.com/vaccine-technologies-market

Table of Contents:

  1.  Introduction
  2.  Research Methodology
  3.  Executive Summary
  4.  Market Overview
     4.1.    Introduction
        4.2.    Drivers
            4.2.1.    Increasing human population
            4.2.2.    Growing demand for pet insurance
            4.2.3.    Rising animal health expenditure
        4.3.    Restraints
            4.3.1.    Highly competitive
        4.4.    Opportunities
            4.4.1.    Advancement in vaccine products
            4.4.2.    Launch of combination products
        4.5.    Challenges
            4.5.1.    Lack of animal health awareness
  5.  Vaccine Technologies Market, By Human Vaccine
  6.  Vaccine Technologies Market, By Animal Vaccine
  7.  Competitive Landscape
  8.  Company Profile
     8.1.    AstraZeneca
            8.1.1.    Company Overview
            8.1.2.    Product/Service Landscape
            8.1.3.    Financial Overview
            8.1.4.    Recent Developments
        8.2.    Boehringer Ingelheim
            8.2.1.    Company Overview
            8.2.2.    Product/Service Landscape
            8.2.3.    Financial Overview
            8.2.4.    Recent Developments
        8.3.    GE Healthcare
            8.3.1.    Company Overview
            8.3.2.    Product/Service Landscape
            8.3.3.    Financial Overview
            8.3.4.    Recent Developments
        8.4.    GlaxoSmithKline
            8.4.1.    Company Overview
            8.4.2.    Product/Service Landscape
            8.4.3.    Financial Overview
            8.4.4.    Recent Developments
        8.5.    Johnson & Johnson
            8.5.1.    Company Overview
            8.5.2.    Product/Service Landscape
            8.5.3.    Financial Overview
            8.5.4.    Recent Developments
        8.6.    LG Life Sciences
            8.6.1.    Company Overview
            8.6.2.    Product/Service Landscape
            8.6.3.    Financial Overview
            8.6.4.    Recent Developments
        8.7.    Novartis
            8.7.1.    Company Overview
            8.7.2.    Product/Service Landscape
            8.7.3.    Financial Overview
            8.7.4.    Recent Developments
        8.8.    Merck
            8.8.1.    Company Overview
            8.8.2.    Product/Service Landscape
            8.8.3.    Financial Overview
            8.8.4.    Recent Developments
        8.9.    Serum Institute Of India
            8.9.1.    Company Overview
            8.9.2.    Product/Service Landscape
            8.9.3.    Financial Overview
            8.9.4.    Recent Developments
        8.10.    Thermo Fisher Scientific
            8.10.1.    Company Overview
            8.10.2.    Product/Service Landscape
            8.10.3.    Financial Overview
            8.10.4.    Recent Developments

Media Contact                                     

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Editor Details

Related Links

Last Updated: 18-Jun-2019